Compare Stocks: BIO, AVTR, and WAT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVTR Avantor	$13.66 -1.4%	$11.21	$7.26 ▼ $15.93	$9.24B	0.89	12.03 million shs	3.96 million shs
BIO Bio-Rad Laboratories	$355.56 -1.6%	$308.58	$236.73 ▼ $365.00	$9.53B	1.06	309,028 shs	173,818 shs
WAT Waters	$411.88 -0.4%	$377.18	$282.77 ▼ $420.26	$40.49B	1.19	928,187 shs	387,602 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVTR Avantor	0.00%	+0.66%	+20.89%	+78.85%	+4.44%
BIO Bio-Rad Laboratories	0.00%	+0.81%	+18.00%	+43.57%	+23.79%
WAT Waters	0.00%	+1.21%	+8.94%	+25.12%	+38.85%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVTR Avantor	$13.66 -1.4%	$11.21	$7.26 ▼ $15.93	$9.24B	0.89	12.03 million shs	3.96 million shs
BIO Bio-Rad Laboratories	$355.56 -1.6%	$308.58	$236.73 ▼ $365.00	$9.53B	1.06	309,028 shs	173,818 shs
WAT Waters	$411.88 -0.4%	$377.18	$282.77 ▼ $420.26	$40.49B	1.19	928,187 shs	387,602 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVTR Avantor	0.00%	+0.66%	+20.89%	+78.85%	+4.44%
BIO Bio-Rad Laboratories	0.00%	+0.81%	+18.00%	+43.57%	+23.79%
WAT Waters	0.00%	+1.21%	+8.94%	+25.12%	+38.85%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVTR Avantor	2.06	Hold	$12.00	-12.12% Downside
BIO Bio-Rad Laboratories	2.00	Hold	$343.33	-3.44% Downside
WAT Waters	2.75	Moderate Buy	$420.35	2.06% Upside

Current Analyst Ratings Breakdown

Latest BIO, AVTR, and WAT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/12/2026	WAT Waters	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Hold (C-)
8/11/2026	BIO Bio-Rad Laboratories	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/10/2026	WAT Waters	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$425.00 ➝ $470.00
8/5/2026	WAT Waters	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$430.00
8/5/2026	WAT Waters	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$400.00
8/5/2026	WAT Waters	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$420.00
8/5/2026	WAT Waters	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$435.00 ➝ $475.00
8/5/2026	WAT Waters	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$420.00
8/5/2026	WAT Waters	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$408.00 ➝ $475.00
8/5/2026	WAT Waters	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$425.00 ➝ $460.00
8/5/2026	BIO Bio-Rad Laboratories	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral ➝ Hold	$300.00 ➝ $330.00

(Data available from 8/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVTR Avantor	$6.55B	1.41	$1.51 per share	9.02	$8.16 per share	1.67
BIO Bio-Rad Laboratories	$2.58B	3.68	$10.00 per share	35.55	$276.16 per share	1.29
WAT Waters	$3.17B	12.78	$16.61 per share	24.79	$43.01 per share	9.58

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVTR Avantor	-$530.20M	-$0.84	N/A	15.70	10.29	-8.81%	9.92%	4.75%	11/4/2026 (Estimated)
BIO Bio-Rad Laboratories	$759.90M	$8.25	43.10	39.38	N/A	8.59%	3.54%	2.48%	10/29/2026 (Estimated)
WAT Waters	$642.63M	$4.01	102.71	24.96	2.40	3.58%	11.27%	6.73%	11/3/2026 (Estimated)

Latest BIO, AVTR, and WAT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/4/2026	Q2 2026	BIO Bio-Rad Laboratories	$1.75	$2.62	+$0.87	$13.85	$623.99 million	$651.00 million
8/4/2026	Q2 2026	WAT Waters	$3.01	$3.05	+$0.04	-$1.39	$1.62 billion	$1.65 billion
7/29/2026	Q2 2026	AVTR Avantor	$0.1915	$0.21	+$0.0185	$0.06	$1.61 billion	$1.69 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVTR Avantor	N/A	N/A	N/A	N/A	N/A
BIO Bio-Rad Laboratories	N/A	N/A	N/A	N/A	N/A
WAT Waters	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVTR Avantor	0.65	1.78	1.18
BIO Bio-Rad Laboratories	0.11	3.14	2.33
WAT Waters	0.32	1.86	1.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVTR Avantor	95.08%
BIO Bio-Rad Laboratories	65.24%
WAT Waters	94.01%

Insider Ownership

Company	Insider Ownership
AVTR Avantor	0.28%
BIO Bio-Rad Laboratories	30.34%
WAT Waters	0.31%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVTR Avantor	13,500	676.36 million	674.47 million	Optionable
BIO Bio-Rad Laboratories	7,450	26.74 million	18.63 million	Optionable
WAT Waters	7,900	98.25 million	97.94 million	Optionable

BIO, AVTR, and WAT Headlines

Recent News About These Companies

Forget Hawaii — this underrated island with gorgeous beaches and turquoise waters is getting more popular in 2026

August 15 at 1:21 PM | msn.com

Warming waters: El Niño brings stingrays, humpback whales, and hammerhead sharks to Southern California

August 15 at 8:20 AM | yahoo.com

Levin Capital Strategies L.P. Sells 3,015 Shares of Waters Corporation $WAT

August 15 at 6:15 AM | marketbeat.com

Milford Funds Ltd. Acquires 68,768 Shares of Waters Corporation $WAT

August 15 at 6:15 AM | marketbeat.com

Sumitomo Mitsui Trust Group Inc. Sells 9,179 Shares of Waters Corporation $WAT

August 15 at 6:07 AM | marketbeat.com

Everett Harris & Co. CA Makes New $11.25 Million Investment in Waters Corporation $WAT

August 15 at 4:39 AM | marketbeat.com

6,268 Shares in Waters Corporation $WAT Purchased by Bryn Mawr Trust Advisors LLC

August 15 at 4:23 AM | marketbeat.com

Daiwa Securities Group Inc. Cuts Holdings in Waters Corporation $WAT

August 15 at 4:16 AM | marketbeat.com

Cooke & Bieler LP Sells 59,117 Shares of Waters Corporation $WAT

August 15 at 4:15 AM | marketbeat.com

Assetmark Inc. Has $1.57 Million Stake in Waters Corporation $WAT

August 15 at 3:12 AM | marketbeat.com

Aberdeen Group plc Acquires 12,570 Shares of Waters Corporation $WAT

August 15 at 3:04 AM | marketbeat.com

iA Global Asset Management Inc. Raises Stake in Waters Corporation $WAT

August 14 at 6:47 AM | marketbeat.com

Swiss Life Asset Management Ltd Increases Holdings in Waters Corporation $WAT

August 14 at 6:47 AM | marketbeat.com

Erste Asset Management GmbH Sells 3,078 Shares of Waters Corporation $WAT

August 14 at 4:24 AM | marketbeat.com

Solo Brands Q2 Sales Fall 4.1% to $88.5 Million

August 13 at 8:30 AM | quiverquant.comQ

Handelsbanken Fonder AB Acquires 45,145 Shares of Waters Corporation $WAT

August 12, 2026 | marketbeat.com

Waters (NYSE:WAT) Sets New 1-Year High - Time to Buy?

August 11, 2026 | marketbeat.com

Tungsten Mining launches major drilling push to de-risk Watershed project

August 10, 2026 | tipranks.com

Dudley & Shanley Inc. Has $8.85 Million Stake in Waters Corporation $WAT

August 10, 2026 | marketbeat.com

Dynamic Advisor Solutions LLC Sells 8,431 Shares of Waters Corporation $WAT

August 10, 2026 | marketbeat.com

Waters Corporation (NYSE:WAT) Receives Average Rating of "Moderate Buy" from Brokerages

August 10, 2026 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BIO, AVTR, and WAT Company Descriptions

Avantor NYSE:AVTR

$13.66 -0.20 (-1.41%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$13.65 0.00 (-0.04%)

As of 08/14/2026 07:34 PM Eastern

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Bio-Rad Laboratories NYSE:BIO

$355.56 -5.63 (-1.56%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$356.36 +0.80 (+0.22%)

As of 08/14/2026 07:34 PM Eastern

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Waters NYSE:WAT

$411.88 -1.63 (-0.39%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$413.99 +2.11 (+0.51%)

As of 08/14/2026 07:34 PM Eastern

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BIO, AVTR, and WAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BIO, AVTR, and WAT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BIO, AVTR, and WAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BIO, AVTR, and WAT Company Descriptions

Avantor NYSE:AVTR

Bio-Rad Laboratories NYSE:BIO

Waters NYSE:WAT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BIO, AVTR, and WAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BIO, AVTR, and WAT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BIO, AVTR, and WAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BIO, AVTR, and WAT Company Descriptions

Avantor NYSE:AVTR

Bio-Rad Laboratories NYSE:BIO

Waters NYSE:WAT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools